Synthetic, yeast-based HCAb platform enables rapid discovery of developable binders for complex multispecifics.

Highly developable soluble T cell receptors (TCRs) with high target affinities discovered from large yeast libraries

Atlas links 15+ years of antibody discovery data across 1,431 programs to power machine learning prediction and natural language querying

Engineered TCR variants show >30,000-fold affinity gains, high specificity, and potent target cell killing

Llama-derived CD3 VHHs enable simpler, modular T-cell engager design with strong functional activity

A case study describing how Adimab's platform translated HLA-G–specific leads into an antibody now in clinical trials